ster

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen
Regen BioPharma, Inc.’s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
Read All Our News >

Pharma News

Pfizer-Lilly pain drug meets late-stage trial goals
Merck lowers prices of some drugs after Trump calls out industry
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice
Read All Pharma News >

New Products &Services

Anti-Parasite Library
Covalent Inhibitors Library
Anti-HIV1 Library
KDM Library